- AU$6.46bn
- AU$7.25bn
- $2.14bn
Morningstar maintains fair value estimates on Aussie health firms despite Trump's 200% tariffs plan
Australia's Ansell slips; Morgan Stanley trims PT on tariff impact concerns
Australia's Ansell falls as Macquarie downgrades to 'neutral', cuts PT
Macquarie downgrades Australia's Ansell to 'neutral', cuts PT
Brief: Ansell To Fully Offset Tariff Increases Through Pricing
Australia's Ansell rises on price hike plan to offset US tariffs
Aussie glove maker Ansell stands to lose most with Trump's 'Liberation Day' tariffs
Brief: Ansell Appointment Of Brian Montgomery To Position Of Chief Financial Officer
Citi ups PT for Australia's Ansell on strong HY earnings
Australia's Ansell hits nearly 3-1/2-year high on forecast hike, earnings beat
Brief: Ansell Says FY25 Adjusted EPS Guidance Range Increased To US118¢ To US128¢
Brief: Ansell Posts H1 Sales Of $1,019.7 Mln
Brief: Ansell Announces Good Organic Constant Currency Sales Growth In Healthcare Segment In Q1
Australia's Ansell hits near 3-yr high on revising FY25 EPS guidance
Brief: Ansell Says CFO Zubair Javeed Has Given Notice Of His Intention To Resign
Analysts raise PT on Australian glove maker Ansell
Australia's Ansell jumps to 19-month high on earnings beat, job cuts
Australian glove maker Ansell at 20-month high on reducing 10% staff
Brief: Ansell Ltd Announces Final Dividend Of US21.90 cents